Tech Company Financing Transactions
Vestaron Funding Round
Vestaron closed a $40 million Series B financing round on 6/11/2019. Investors included Novo Ventures, Anterra Capital and Cultivian Sandbox.
Transaction Overview
Company Name
Announced On
6/11/2019
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
Novo Ventures (Lead Investor) (Anders Spohr)
Anterra Capital (Phil Austin)
Proceeds Purpose
The company will use the additional funds to support the commercialization of its Spear family of products, including expansion into new geographies, and to accelerate the development of its pipeline of additional peptide-based biopesticides.
Company Information
Company Status
Private & Independent
Industry
Clean Tech
Mailing Address
600 Park Offices Dr. 117
Durham, NC 27709
USA
Durham, NC 27709
USA
Phone
Website
Email Address
Overview
Vestaron Corporation is developing a new generation of insecticides by employing peptides sourced from spiders -- insecticides that are ideally suited for the environmentally conscious, twenty-first century. Over 50 unique, spider-venom peptides with novel sites of action have been identified and are being exploited.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anna Rath
Chief Financial Officer
Jessica Vanhoy
Chief Scientific Officer
Robert Kennedy
VP - Bus. Development
Andrew Renz
VP - Operations
Jason Noel
VP - Regulatory Affairs
Scott Jackson
VP - Sales
Benjamin Cicora
Browse more venture capital transactions:
Prev: 6/11/2019: Getaway venture capital transaction
Next: 6/11/2019: Ikin venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs